AI Assistant
Blog
Pricing
Log In
Sign Up
Retraction: Efficacy of a novel DPP-4 inhibitor, teneligliptin, for hemodialysis patients with type 2 diabetes
Details
Cite
Export
Add to List
The content you want is available to Zendy users.
Already have an account? Click
here.
to sign in.
